These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 126635

  • 1. Urinary excretion of glycosaminoglycans in malignant diseases of the haemopoietic and lymphatic tissues.
    Friman C, Juvani M.
    Acta Med Scand; 1975; 198(1-2):115-22. PubMed ID: 126635
    [Abstract] [Full Text] [Related]

  • 2. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P, Faedda R, Satta A, Finetti D, Masala A, Cigni A, Sanna GM, Cherchi GM.
    J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
    [Abstract] [Full Text] [Related]

  • 3. [Urinary elimination of beta aminoisobutyric acid in malignant hemopathies].
    Roulaud F, Boisseau M, Moreau F, Labatut M.
    C R Seances Soc Biol Fil; 1971; 165(1):83-7. PubMed ID: 4257756
    [No Abstract] [Full Text] [Related]

  • 4. Urinary polyamines in cancer patients.
    Russell DH, Levy CC, Schimpff SC, Hawk IA.
    Cancer Res; 1971 Nov; 31(11):1555-8. PubMed ID: 4941348
    [No Abstract] [Full Text] [Related]

  • 5. Urinary amino acid excretion in subjects with leukaemia.
    Lee MB, Neill DW, Bridges JM.
    J Clin Pathol; 1967 Jan; 20(1):70-4. PubMed ID: 5225727
    [Abstract] [Full Text] [Related]

  • 6. Beta trace protein. Purification and urinary excretion studies in selected diseases.
    Whitsed H, Penny R.
    Clin Chim Acta; 1974 Jan 19; 50(1):111-8. PubMed ID: 4205928
    [No Abstract] [Full Text] [Related]

  • 7. Urinary glycosaminoglycans in patients with systemic lupus erythematosus.
    De Muro P, Faedda R, Formato M, Re F, Satta A, Cherchi GM, Carcassi A.
    Clin Exp Rheumatol; 2001 Jan 19; 19(2):125-30. PubMed ID: 11326473
    [Abstract] [Full Text] [Related]

  • 8. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P, Fresu P, Formato M, Tonolo G, Mameli M, Maioli M, Sanna GM, Cherchi GM.
    J Nephrol; 2002 Jan 19; 15(3):290-6. PubMed ID: 12113601
    [Abstract] [Full Text] [Related]

  • 9. Urinary neopterine in the assessment of lymphoid and myeloid neoplasia, and neopterine levels in haemolytic anaemia and benign monoclonal gammopathy.
    Hausen A, Fuchs D, Grünewald K, Huber H, König K, Wachter H.
    Clin Biochem; 1982 Feb 19; 15(1):34-7. PubMed ID: 7067074
    [Abstract] [Full Text] [Related]

  • 10. The excretion of tryptophan metabolites in patients with different forms of haemoblastosis.
    Mauri C, Coppini D, Silingardi V, Plessi M.
    Acta Vitaminol Enzymol; 1975 Feb 19; 29(1-6):132-9. PubMed ID: 1244082
    [Abstract] [Full Text] [Related]

  • 11. [Biochemical findings in body fluids in leukemia patients. Changes in the urine].
    Ledvina M.
    Z Gesamte Inn Med; 1967 Jul 15; 22(14):409-15. PubMed ID: 4233203
    [No Abstract] [Full Text] [Related]

  • 12. [Excretion of beta-aminoisobutyric acid in health, in systemic lupus erythematosus and leukemia].
    Mazurik VK, Kondrat'eva AP, Bryskina LE, Nasonova VA.
    Vopr Med Khim; 1969 Jul 15; 15(1):70-5. PubMed ID: 5258856
    [No Abstract] [Full Text] [Related]

  • 13. Virus-like particles and cytopathic activity in urine of patients with leukemia.
    Ames RP, Sobota JT, Reagan RL, Karon M.
    Blood; 1966 Sep 15; 28(3):465-78. PubMed ID: 5223201
    [No Abstract] [Full Text] [Related]

  • 14. [ATTEMPT AT TREATMENT OF HODGKIN'S DISEASE AND VARIOUS HEMATOSARCOMAS WITH 1-METHYL-2-P-ALLOPHANOYL-BENZYLHYDRAZINE HYDROBROMIDE].
    MATHE G, SCHNEIDER M, CATTAN A, AMIEL JL, SCHWARZENBERG L, SCHLUMBERGER JR.
    Rev Fr Etud Clin Biol; 1964 Nov 15; 9():990-2. PubMed ID: 14232681
    [No Abstract] [Full Text] [Related]

  • 15. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D, Schiby G, Rosenblatt K, Or R, Hodak E.
    Br J Dermatol; 2006 Aug 15; 155(2):379-86. PubMed ID: 16882178
    [Abstract] [Full Text] [Related]

  • 16. Interference of an algal nutritional supplement with a urinary metabolic screening test for glycosaminoglycans in a dog suspected to have a storage disease.
    Sewell AC, Pankraz A.
    Vet Clin Pathol; 2013 Dec 15; 42(4):504-7. PubMed ID: 24320782
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Specchia G, Montanaro M, Barbui AM, Nieddu R, Pagano L, Rapicetta M, Franceschi S, Mandelli F, Pulsoni A, Italian Multi-Center case-control study.
    Haematologica; 2004 Jan 15; 89(1):70-6. PubMed ID: 14754608
    [Abstract] [Full Text] [Related]

  • 18. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD, Srivastava A, Srivastava BI.
    Leuk Lymphoma; 1994 Jan 15; 12(3-4):241-51. PubMed ID: 7909467
    [Abstract] [Full Text] [Related]

  • 19. [Excretion of 17-ketosteroid fractions in leukemic patients following ACTH therapy].
    Szatmári E, Fehér T.
    Klin Wochenschr; 1966 Nov 15; 44(22):1314-5. PubMed ID: 4296213
    [No Abstract] [Full Text] [Related]

  • 20. Urinary excretion of glycosaminoglycans in neoplastic diseases of children.
    Strisciuglio P, Fiorillo A, Costabile M, Montini T.
    Eur J Pediatr; 1989 Apr 15; 148(6):584. PubMed ID: 2744030
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.